MedTrace Logo

Study on Treatment of Varicose Veins by Endovenous Laser (1940 nm vs 1470 nm)

NCT05663359 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2026-03-06

No results posted yet for this study

Summary

The goal of this clinical trial is to compare efficacy of two wavelength for EndoVenous Laser Ablation (EVLA) in treatment of varicose veins of the lower limbs.

The main questions it aims to answers are :

1. Is the increase of wavelength form 1470 nm to 1940 nm affect the efficacy of varicose veins treatment ?
2. Is the increase of wavelength reduce complication or pain ? Participants are patients with varicose veins of lower limbs and candidate for endovenous laser ablation.

After laser ablation patients will be followed during 5 years for clinical evaluation, recording potential treatment complications and quality of life evaluation.

Researchers will compare strategy 1(EVLA with an endovenous laser at 1940 nm) vs strategy 2 (EVLA with an endovenous laser at 1470 nm) in varicose veins treatment to see if efficacy of treatment is not reduce, and to see if complications of EVLA treatment can be reduced.

Conditions

  • Varicose Veins

Interventions

PROCEDURE

EVLA 1940 nm

Treatment of varicose veins by endothermic ablation with an endovenous laser at 1940 nm

PROCEDURE

EVLA 1470 nm

Treatment of varicose veins by endothermic ablation with an endovenous laser at 1470 nm

Sponsors & Collaborators

  • Clinique Pasteur

    lead OTHER

Principal Investigators

  • Nicolas NEAUME, MD · Clinique Pasteur

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-24
Primary Completion
2032-02-29
Completion
2032-02-29

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05663359 on ClinicalTrials.gov